ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine

Stock Information for Network-1 Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Network-1 Technologies Inc.

Network-1 Reports 2023 Year-End Financial Results
Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 51 Patents Worldwide
Network-1 Declares Semi-Annual Dividend
Press release 58740 - See attachment
Network-1 Declares Semi-Annual Dividend
Network-1 Receives New eSIM Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 50 Patents Worldwide
Network-1 Reports Second Quarter Results
Network-1 Extends its Share Repurchase Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.